Verastem, Inc. (VSTM)
6.325
-0.54
(-7.80%)
USD |
NASDAQ |
Nov 20, 16:00
6.34
+0.02
(+0.24%)
After-Hours: 20:00
Verastem Gross Profit (TTM) : 86.37M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 86.37M |
| June 30, 2026 | 75.58M |
| March 31, 2026 | 41.11M |
| December 31, 2025 | 25.48M |
| September 30, 2025 | 10.83M |
| June 30, 2025 | 1.539M |
| March 31, 2025 | 9.97M |
| December 31, 2024 | 9.974M |
| September 30, 2024 | 9.976M |
| June 30, 2024 | 9.978M |
| March 31, 2024 | -0.038M |
| December 31, 2023 | -0.062M |
| September 30, 2023 | -0.086M |
| June 30, 2023 | -0.111M |
| March 31, 2023 | -0.118M |
| December 31, 2022 | -0.118M |
| September 30, 2022 | -0.119M |
| June 30, 2022 | -0.089M |
| March 31, 2022 | -0.06M |
| December 31, 2021 | -0.03M |
| September 30, 2021 | 0.413M |
| June 30, 2021 | 7.925M |
| March 31, 2021 | 11.35M |
| December 31, 2020 | 15.43M |
| September 30, 2020 | 17.81M |
| Date | Value |
|---|---|
| June 30, 2020 | 18.46M |
| March 31, 2020 | 17.29M |
| December 31, 2019 | 14.22M |
| September 30, 2019 | 12.02M |
| June 30, 2019 | 19.19M |
| March 31, 2019 | 16.93M |
| December 31, 2018 | 15.80M |
| September 30, 2018 | 15.08M |
| June 30, 2018 | -0.391M |
| March 31, 2018 | -0.391M |
| December 31, 2017 | -0.412M |
| September 30, 2017 | -0.436M |
| June 30, 2017 | -0.457M |
| March 31, 2017 | -0.633M |
| December 31, 2016 | -0.67M |
| September 30, 2016 | -0.706M |
| June 30, 2016 | -0.736M |
| March 31, 2016 | -0.749M |
| December 31, 2015 | -0.754M |
| September 30, 2015 | -0.751M |
| June 30, 2015 | -0.663M |
| March 31, 2015 | -0.551M |
| December 31, 2014 | -0.427M |
| September 30, 2014 | -0.304M |
| June 30, 2014 | -0.265M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 422.57M |
| Cytokinetics, Inc. | 89.41M |
| Inovio Pharmaceuticals, Inc. | -2.748M |
| Rigel Pharmaceuticals, Inc. | 258.34M |
| United Therapeutics Corp. | 2.752B |